Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PhRMA Seeking Injunction Against 340B Orphan Drug Exclusion Rule

This article was originally published in The Pink Sheet Daily

Executive Summary

The trade group files a lawsuit seeking preliminary and permanent injunctions against implementation of a final rule that requires 340B discounts for the non-orphan uses of drugs with an orphan designation.


Related Content

340B Orphan Drug Rule Overturned In Court, Putting Future Regs Into Question
340B Meets Part B: Payment Proposal Unites Big Pharma and Safety Net Providers
PhRMA Sues FTC To Halt Rule On Drug Patent Licensing Deals
FDA In Twilight: Gov’t Shutdown Has Not Slowed Rx Operations Too Visibly Yet
340B Final Rule Keeps Orphan Drug Exclusion Narrow, Counter To Manufacturers’ Request
340B Orphan Drug Rule: Stakeholders Are Parsing ACA Statute – Should Some Indications Be Cheaper Than Others?





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts